全文获取类型
收费全文 | 21523篇 |
免费 | 850篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 375篇 |
儿科学 | 671篇 |
妇产科学 | 450篇 |
基础医学 | 3403篇 |
口腔科学 | 437篇 |
临床医学 | 1591篇 |
内科学 | 4073篇 |
皮肤病学 | 826篇 |
神经病学 | 1914篇 |
特种医学 | 1163篇 |
外国民族医学 | 23篇 |
外科学 | 3141篇 |
综合类 | 67篇 |
一般理论 | 9篇 |
预防医学 | 1158篇 |
眼科学 | 357篇 |
药学 | 1650篇 |
中国医学 | 17篇 |
肿瘤学 | 1070篇 |
出版年
2023年 | 119篇 |
2021年 | 160篇 |
2020年 | 139篇 |
2019年 | 193篇 |
2018年 | 347篇 |
2017年 | 285篇 |
2016年 | 400篇 |
2015年 | 459篇 |
2014年 | 474篇 |
2013年 | 652篇 |
2012年 | 981篇 |
2011年 | 975篇 |
2010年 | 550篇 |
2009年 | 446篇 |
2008年 | 888篇 |
2007年 | 957篇 |
2006年 | 971篇 |
2005年 | 935篇 |
2004年 | 860篇 |
2003年 | 829篇 |
2002年 | 814篇 |
2001年 | 780篇 |
2000年 | 879篇 |
1999年 | 706篇 |
1998年 | 203篇 |
1997年 | 152篇 |
1996年 | 133篇 |
1995年 | 104篇 |
1992年 | 338篇 |
1991年 | 364篇 |
1990年 | 353篇 |
1989年 | 312篇 |
1988年 | 263篇 |
1987年 | 270篇 |
1986年 | 228篇 |
1985年 | 236篇 |
1984年 | 182篇 |
1983年 | 116篇 |
1982年 | 118篇 |
1979年 | 195篇 |
1978年 | 133篇 |
1977年 | 120篇 |
1975年 | 150篇 |
1974年 | 133篇 |
1973年 | 155篇 |
1972年 | 143篇 |
1971年 | 129篇 |
1970年 | 131篇 |
1969年 | 123篇 |
1967年 | 121篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Martin R. Späth Malte P. Bartram Nicolàs Palacio-Escat K. Johanna R. Hoyer Cedric Debes Fatih Demir Christina B. Schroeter Amrei M. Mandel Franziska Grundmann Giuliano Ciarimboli Andreas Beyer Jayachandran N. Kizhakkedathu Susanne Brodesser Heike Göbel Jan U. Becker Thomas Benzing Bernhard Schermer Martin Höhne Markus M. Rinschen 《Kidney international》2019,95(2):333-349
3.
4.
5.
More than just crushing: a prospective pre‐post intervention study to reduce drug preparation errors in patients with feeding tubes 下载免费PDF全文
6.
Poor results after surgery for bronchioloalveolar carcinoma. 总被引:2,自引:0,他引:2
R A M Damhuis P R Schütte O C M Varin P M van den Berg R Heinhuis P W Plaisier 《European journal of surgical oncology》2006,32(5):573-576
BACKGROUND: Bronchioloalveolar carcinoma (BAC) is suggested to be less aggressive than other types of lung cancer. To assess the option of treatment modification, actual outcome data were studied and compared with results for other types of lung cancer. METHOD: Retrospective analysis of all consecutive patients who underwent resection for stage I lung cancer in our hospital. For 18 BAC cases, histological specimens were re-evaluated and in three cases diagnosis was revised. RESULTS: In the period 1989 through 2000, 15 patients with BAC and 260 patients with other tumour types underwent surgery in our hospital. Five-year survival rates were 24 and 53%, respectively, (p = 0.01). CONCLUSIONS: Given the poor results after standard surgery, parenchyma-sparing operations do not seem justified in patients with invasive BAC. 相似文献
7.
8.
C Schmitt J Brachmann W Saggau T Beyer B Waldecker K Scharowski T Hilbel M Montero B Offner W Sch?ls 《Zeitschrift für Kardiologie》1991,80(11):665-672
In 41 patients with recurrent sustained ventricular tachycardia and/or ventricular fibrillation an integrated pacemaker-defibrillator-system (PCD, Medtronic, model 7216 A or 7217 B) was implanted. In 21 out of 24 (88%) patients a new transvenous implantation technique in combination with a subcutaneous patch electrode was used. The implanted devices comprise antibradycardiac pacemaker functions, two different forms of antitachycardiac pacemaker functions (ramp and burst pacing), and internal cardioversion or defibrillation capabilities. During a mean follow-up of 8 months 147 episodes of ventricular tachycardia were detected, 131 of them were terminated successfully by antitachycardiac pacing; in 13 episodes internal cardioversion was applied to revert ventricular tachycardia. Twenty-seven episodes of ventricular fibrillation or rapid ventricular tachycardia (greater than 200/min) were detected and successfully terminated by internal defibrillation. In six patients with intermittent rapid atrial fibrillation, change of antiarrhythmic therapy was required to avoid activation of the device. The new integrated pacemaker-defibrillator systems improve therapy in patients with life-threatening tachyarrhythmias by reducing the number of internal cardioversions/defibrillations; the non-thoracotomy approach reduces the post operative risk. 相似文献
9.
W. Nörenberg Ernst Schöffel Bela Szabo Klaus Starke 《Naunyn-Schmiedeberg's archives of pharmacology》1997,356(2):159-165
The aim of the study was to subclassify the soma-dendritic α2-autoreceptors in the locus coeruleus (LC) of the rat by means of antagonists. To this end, the frequency of spontaneous action
potentials was recorded extracellularly from single LC neurones in brain slices. The neurones fired spontaneously at an average
rate of 1 Hz. The selective α2-adrenoceptor agonist 5-bromo-6-(2-imidazolin-2-ylamino)-quinoxaline (UK 14,304) and noradrenaline decreased the action potential
discharge with IC50 values of 5 and 510 nM, respectively. The concentration-inhibition curves of UK 14,304 and noradrenaline were shifted to the
right by phentolamine (0.15 μM) and rauwolscine (0.15 μM) but not by prazosin (1 μM). Apparent K
d values of phentolamine were 17 nM (against UK 14,304) and 20 nM (against noradrenaline). Apparent K
d values of rauwolscine were 47 nM (against UK 14,304) and 70 nM (against noradrenaline). (+)-Oxaprotiline (1 μM) suppressed
the firing of the neurones within 10 to 33 min. In the continued presence of oxaprotiline, phentolamine and rauwolscine restored
firing with EC50 values of 120 and 250 nM, respectively. Prazosin (1 μM) again was ineffective. All three antagonist affinity estimates –
against UK 14,304, exogenous noradrenaline and endogenous noradrenaline (that accumulates in the extracellular space in the
presence of oxaprotiline) – yield an affinity order phentolamine > rauwolscine >> prazosin, prazosin being ineffective even
at a concentration of 1 μM. These findings identify the soma-dendritic α2-autoreceptors of the LC as the rat variant of the α2A/D-adrenoceptor, i.e. α2D. Not only presynaptic but also soma-dendritic α2-autoreceptors may at least predominantly be α2A/D throughout the nervous system.
Received: 3 March 1997 / Accepted: 21 April 1997 相似文献
10.
K. Reynen U. Röber W.G. Daniel R. Henßge S. Schüler 《Clinical research in cardiology》1998,87(5):331-335
Zusammenfassung Zahlen zur H?ufigkeit von Herztumoren im operativen Krankengut liegen bisher für die Bundesrepublik Deutschland nicht vor.
Um einen entsprechenden überblick für das Jahr 1996 zu erhalten, wurde allen 77 herzchirurgischen Zentren der Bundesrepublik
Deutschland ein standardisierter Fragebogen zugesandt.
Daten von 65 der 77 Herzzentren (=84%) waren schlie?lich verfügbar: 187 Patienten waren wegen Myxomen, lediglich 44 wegen
nichtmyxomat?sen Tumoren, davon 28 wegen malignen prim?ren oder sekund?ren Herztumoren, operiert worden. Im Jahr 1996 waren
somit 0,32% (231/72 763) der Eingriffe mit Herz-Lungen-Maschine (erfa?t 72 763 von insgesamt 87 372) wegen eines Herztumors
vorgenommen worden. Ausgehend von diesen operativen Daten liegt die Inzidenz ausschlie?lich der prim?ren Tumoren des Herzens
zumindest bei 3 Tumoren pro 1 Million Einwohner pro Jahr (253 Tumoren/81,814 Millionen Einwohner). Wenn auch kleine Tumoren
asymptomatisch und unentdeckt bleiben k?nnen, wird heute doch die Mehrzahl prim?rer kardialer Tumoren durch Echokardiographie,
Computer- und Kernspintomographie bereits zu Lebzeiten des Patienten diagnostiziert, und diese Patienten werden in aller Regel
einer Operation zugeführt.
Somit werden gut 0,3% aller Eingriffe mit Herz-Lungen-Maschine in Deutschland wegen Herztumoren durchgeführt, wobei es sich
weit überwiegend um Myxome handelt.
Eingegangen: 23. September 1997, Akzeptiert: 11. Februar 1998 相似文献